- Robotic vs conventional laparoscopic gastrectomy for gastric cancer: A retrospective cohort study
- Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT
- Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) Lenvatinib in Differentiated Cancer of the Thyroid (SELECT)
- Pretreatment tumor thickness as a predictor of pathologic complete response to neoadjuvant chemoradiation therapy for stage II/III rectal adenocarcinoma
- Normalization of C-reactive protein levels following cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors is associated with improved overall survival
- Budding and tumor infiltrating lymphocytes – combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups
- Lung cancer mortality and exposure to synthetic metalworking fluid and biocides: Controlling for the healthy worker survivor effect
- Prognostic factors, treatment, and outcomes in early stage, invasive papillary breast cancer: A SEER investigation of less aggressive treatment in a favorable histology
- Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer
- Presence of intratumoral calcifications and vasculature is associated with poor overall survival in clear cell renal cell carcinoma
- Absolute CBV for the differentiation of recurrence and radionecrosis of brain metastases after gamma knife radiotherapy: A comparison with relative CBV
- Robotic vs laparoscopic minimally invasive surgery for rectal cancer: A systematic review and meta-analysis of randomized controlled trials
- Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer
- Comparison of up-front radiotherapy and TKI with TKI alone for NSCLC with brain metastases and EGFR mutation: A meta-analysis
- Severe neurologic complications of immune checkpoint inhibitors: A single-center review
Feed Sources
